Search
CER-001
go.drugbank.com/drugs/DB18538Investigational[L48290] It is under investigation for the treatment of lecithin-cholesterol acyltransferase (LCAT) deficiencies.
Safimaltib
go.drugbank.com/drugs/DB21528InvestigationalSafimaltib is under investigation in clinical trial NCT06788509 (A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring).
Terevalefim
go.drugbank.com/drugs/DB16397InvestigationalTerevalefim is under investigation in clinical trial NCT02474667 (Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney).
Dovitinib
go.drugbank.com/drugs/DB05928InvestigationalChiron currently has three ongoing Phase I clinical trials for dovitinib.
Pirisudanol
go.drugbank.com/drugs/DB13412ExperimentalCategories: Psychostimulants, Agents Used for ADHD and NootropicsMetisazone
go.drugbank.com/drugs/DB13641ExperimentalCategories: Antivirals for Systemic Use, Antiinfectives for Systemic UseLascufloxacin
go.drugbank.com/drugs/DB20002ExperimentalLascufloxacin is a small molecule drug. The usage of the INN stem '-oxacin' in the name indicates that Lascufloxacin is a nalidixic acid derivative antibacterial. Lascufloxacin has a monoisotopic molecular weight of 439.17 Da.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseFM-VP4
go.drugbank.com/drugs/DB05449InvestigationalFM-VP4, is a novel hydrophilic phytostanol analogue representing a new class in cholesterol-lowering drugs called cholesterol absorption inhibitors. FM-VP4 has been shown to inhibit cholesterol absorption and to lower plasma LDL-choleste...